ClearPoint Neuro (CLPT) Asset Utilization Ratio (2012 - 2026)
ClearPoint Neuro (CLPT) reported Asset Utilization Ratio of 0.42 for Q1 2026, down 54.35% on a YoY basis from 0.93 in Q1 2025, and down 9.14% sequentially from 0.47 in Q4 2025.
ClearPoint Neuro (CLPT) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 14 years of Asset Utilization Ratio data on file, last reported at 0.42 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 54.35% year-over-year to 0.42; the trailing twelve-month figure through Mar 2026 stood at 0.42 (down 54.35% YoY), and the FY2025 full-year result was 0.54, down 29.6% from the prior year.
- Asset Utilization Ratio fell to 0.42 in Q1 2026, from 0.47 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.93 in Q1 2025 to a low of 0.27 in Q1 2022.
- A 5-year average of 0.52 and a median of 0.49 in 2023 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio soared 71.33% in 2025 and plunged 54.35% in 2026, its largest moves.
- Tracing CLPT's Asset Utilization Ratio over 5 years: stood at 0.36 in 2022, then jumped by 52.58% to 0.55 in 2023, then surged by 42.78% to 0.79 in 2024, then sank by 40.86% to 0.47 in 2025, then decreased by 9.14% to 0.42 in 2026.
- Business Quant data shows CLPT's Asset Utilization Ratio at 0.42 in Q1 2026, 0.47 in Q4 2025, and 0.56 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.56 |
| Jun 30, 2025 | 0.72 |
| Mar 31, 2025 | 0.93 |
| Dec 31, 2024 | 0.79 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.54 |
| Dec 31, 2023 | 0.55 |
| Sep 30, 2023 | 0.49 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.31 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | 0.24 |
| Sep 30, 2021 | 0.22 |
| Jun 30, 2021 | 0.20 |